Role of ADAM15 in Tumor/Endothelial Interactions Prostate Cancer Regression
Abstract
The primary purpose of this proposal was to demonstrate that the membrane disintegrin, ADAM-15 mediates the interaction (binding) between prostate tumor cells and vascular endothelium and that in this regard ADAM-15 would support the metastatic spread of human prostate cancer. The successful completion of one of the earliest aspects of this proposal has given substance to the hypothesis and confidence as we move ahead with more functional analysis of this mechanism. These results clearly justify continuing with the proposed studies and may ultimately justify ADAM15 as a direct therapeutic target for metastatic prostate cancer.
Document Details
- Document Type
- Technical Report
- Publication Date
- Mar 01, 2008
- Accession Number
- ADA493686
Entities
People
- Mark L. Day
Organizations
- University of Michigan